Abstract:Obesity is one of the major health burdens of the 21st century as it contributes to the growing prevalence of its related comorbidities, including insulin resistance and type 2 diabetes. Growing evidence suggests a critical role for overnutrition in the development of low-grade inflammation. Specifically, chronic inflammation in adipose tissue is considered a crucial risk factor for the development of insulin resistance and type 2 diabetes in obese individuals. The triggers for adipose tissue inflammation are still poorly defined. However, obesity-induced adipose tissue expansion provides a plethora of intrinsic signals (e.g., adipocyte death, hypoxia, and mechanical stress) capable of initiating the inflammatory response. Immune dysregulation in adipose tissue of obese subjects results in a chronic low-grade inflammation characterized by increased infiltration and activation of innate and adaptive immune cells. Macrophages are the most abundant innate immune cells infiltrating and accumulating into adipose tissue of obese individuals; they constitute up to 40% of all adipose tissue cells in obesity. In obesity, adipose tissue macrophages are polarized into pro-inflammatory M1 macrophages and secrete many pro-inflammatory cytokines capable of impairing insulin signaling, therefore promoting the progression of insulin resistance. Besides macrophages, many other immune cells (e.g., dendritic cells, mast cells, neutrophils, B cells, and T cells) reside in adipose tissue during obesity, playing a key role in the development of adipose tissue inflammation and insulin resistance. The association of obesity, adipose tissue inflammation, and metabolic diseases makes inflammatory pathways an appealing target for the treatment of obesity-related metabolic complications. In this review, we summarize the molecular mechanisms responsible for the obesity-induced adipose tissue inflammation and progression toward obesity-associated comorbidities and highlight the current therapeutic strategies.

Aging, Obesity, and Inflammatory Age-Related Diseases

The Impact of Aging on Adipose Function and Adipokine Synthesis

Implications of Inflammatory States on Dysfunctional Immune Responses in Aging and Obesity

Adipose Tissue: A Tertiary Lymphoid Organ: Does It Change with Age?

The interplay between obesity, immunosenescence, and insulin resistance

The role of autoantibodies in bridging obesity, aging, and immunosenescence

Adipose tissue aging is regulated by an altered immune system

Editorial: Obesity and Accelerated Aging

Obesity May Accelerate the Aging Process

Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes

Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity.

Obesity-induced chronic low-grade inflammation in adipose tissue: A pathway to Alzheimer's disease

Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines

Adipose Tissue Aging and Metabolic Disorder, and the Impact of Nutritional Interventions

Obesity and aging: Molecular mechanisms and therapeutic approaches

Several areas of overlap between obesity and aging indicate obesity as a biomarker of accelerated aging of human B cell function and antibody responses

Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue

Obesity in the elderly: who should we be treating, and why, and how?

Aging human body: changes in bone, muscle and body fat with consequent changes in nutrient intake.

Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences

Aging Up-Regulates Expression of Inflammatory Mediators in Mouse Adipose Tissue